 John Rinn
Concepts (582)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 64 | 2024 | 181 | 17.240 |
Why?
| | RNA, Untranslated | 27 | 2021 | 124 | 6.080 |
Why?
| | Gene Expression Regulation | 49 | 2024 | 2607 | 4.470 |
Why?
| | Chromatin | 26 | 2023 | 519 | 3.830 |
Why?
| | RNA | 17 | 2024 | 921 | 2.770 |
Why?
| | Cell Nucleus | 14 | 2025 | 620 | 2.560 |
Why?
| | Transcription, Genetic | 29 | 2024 | 1457 | 2.390 |
Why?
| | Genome | 12 | 2022 | 300 | 2.260 |
Why?
| | Epigenesis, Genetic | 18 | 2024 | 660 | 2.170 |
Why?
| | Genome, Human | 18 | 2021 | 425 | 2.160 |
Why?
| | Enhancer Elements, Genetic | 10 | 2020 | 190 | 1.940 |
Why?
| | RNA, Messenger | 25 | 2021 | 2833 | 1.940 |
Why?
| | Promoter Regions, Genetic | 16 | 2021 | 1250 | 1.930 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2017 | 528 | 1.840 |
Why?
| | RNA-Binding Proteins | 15 | 2024 | 422 | 1.830 |
Why?
| | Repetitive Sequences, Nucleic Acid | 3 | 2021 | 113 | 1.660 |
Why?
| | Models, Genetic | 8 | 2018 | 600 | 1.610 |
Why?
| | Sequence Analysis, RNA | 14 | 2019 | 452 | 1.390 |
Why?
| | Transcriptome | 12 | 2025 | 971 | 1.380 |
Why?
| | Cell Differentiation | 25 | 2023 | 1991 | 1.360 |
Why?
| | Ribonucleoproteins | 4 | 2025 | 105 | 1.350 |
Why?
| | Telomerase | 4 | 2024 | 250 | 1.330 |
Why?
| | X Chromosome Inactivation | 6 | 2024 | 25 | 1.330 |
Why?
| | Gene Deletion | 6 | 2021 | 391 | 1.320 |
Why?
| | Animals | 92 | 2025 | 36940 | 1.280 |
Why?
| | Introns | 6 | 2025 | 258 | 1.240 |
Why?
| | CCCTC-Binding Factor | 3 | 2024 | 14 | 1.230 |
Why?
| | Fibroblasts | 10 | 2018 | 996 | 1.180 |
Why?
| | Mice | 60 | 2025 | 17787 | 1.140 |
Why?
| | Base Sequence | 18 | 2020 | 2181 | 1.140 |
Why?
| | Open Reading Frames | 8 | 2024 | 123 | 1.110 |
Why?
| | Genomics | 13 | 2022 | 795 | 1.090 |
Why?
| | Chromosomes | 3 | 2018 | 107 | 1.070 |
Why?
| | DNA, Complementary | 8 | 2020 | 272 | 1.070 |
Why?
| | Genetic Loci | 7 | 2020 | 288 | 1.030 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 31 | 1.030 |
Why?
| | Embryonic Stem Cells | 10 | 2015 | 129 | 1.020 |
Why?
| | RNA Splicing | 7 | 2025 | 269 | 0.980 |
Why?
| | RNA, Nuclear | 1 | 2025 | 5 | 0.980 |
Why?
| | Gene Expression Regulation, Developmental | 16 | 2023 | 860 | 0.950 |
Why?
| | Molecular Sequence Annotation | 7 | 2020 | 99 | 0.900 |
Why?
| | Transcription Factors | 17 | 2020 | 1719 | 0.900 |
Why?
| | Gene Expression Profiling | 29 | 2020 | 1774 | 0.870 |
Why?
| | Hematopoiesis | 3 | 2021 | 192 | 0.870 |
Why?
| | Humans | 121 | 2025 | 137585 | 0.850 |
Why?
| | DNA Damage | 2 | 2017 | 420 | 0.840 |
Why?
| | Cell Line | 17 | 2024 | 2847 | 0.830 |
Why?
| | Mice, Knockout | 14 | 2024 | 3015 | 0.820 |
Why?
| | Induced Pluripotent Stem Cells | 7 | 2021 | 248 | 0.810 |
Why?
| | Fertility | 2 | 2020 | 160 | 0.770 |
Why?
| | Microscopy, Confocal | 3 | 2018 | 325 | 0.760 |
Why?
| | Pluripotent Stem Cells | 6 | 2022 | 80 | 0.740 |
Why?
| | Regulatory Elements, Transcriptional | 4 | 2020 | 19 | 0.740 |
Why?
| | Binding Sites | 13 | 2024 | 1303 | 0.740 |
Why?
| | Polycomb Repressive Complex 2 | 5 | 2020 | 67 | 0.720 |
Why?
| | Computational Biology | 7 | 2021 | 644 | 0.720 |
Why?
| | Ebolavirus | 4 | 2023 | 35 | 0.710 |
Why?
| | Hemorrhagic Fever, Ebola | 4 | 2023 | 36 | 0.710 |
Why?
| | Cellular Reprogramming | 4 | 2018 | 99 | 0.690 |
Why?
| | Cytoplasm | 3 | 2022 | 274 | 0.680 |
Why?
| | Evolution, Molecular | 4 | 2020 | 493 | 0.670 |
Why?
| | Sequence Deletion | 3 | 2020 | 183 | 0.670 |
Why?
| | Body Patterning | 4 | 2008 | 132 | 0.660 |
Why?
| | DNA | 7 | 2022 | 1459 | 0.660 |
Why?
| | Nucleic Acid Conformation | 7 | 2024 | 728 | 0.640 |
Why?
| | K562 Cells | 5 | 2021 | 89 | 0.630 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2189 | 0.620 |
Why?
| | Embryonic Development | 6 | 2019 | 119 | 0.620 |
Why?
| | Repressor Proteins | 7 | 2018 | 427 | 0.610 |
Why?
| | Alleles | 6 | 2024 | 891 | 0.610 |
Why?
| | Oligonucleotide Array Sequence Analysis | 17 | 2016 | 767 | 0.610 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 1502 | 0.610 |
Why?
| | In Situ Hybridization, Fluorescence | 7 | 2021 | 317 | 0.600 |
Why?
| | Organ Specificity | 6 | 2019 | 305 | 0.590 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2900 | 0.570 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.570 |
Why?
| | Time-Lapse Imaging | 1 | 2018 | 21 | 0.570 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 812 | 0.570 |
Why?
| | Chromosomes, Human, X | 1 | 2018 | 73 | 0.560 |
Why?
| | Endogenous Retroviruses | 2 | 2022 | 37 | 0.560 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 156 | 0.560 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 433 | 0.550 |
Why?
| | DNA Methylation | 8 | 2022 | 643 | 0.550 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2019 | 1396 | 0.520 |
Why?
| | Phenotype | 8 | 2024 | 3196 | 0.500 |
Why?
| | Genomic Imprinting | 3 | 2024 | 26 | 0.500 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.490 |
Why?
| | DNA, Satellite | 1 | 2015 | 18 | 0.490 |
Why?
| | Gene Regulatory Networks | 7 | 2018 | 305 | 0.490 |
Why?
| | Homeodomain Proteins | 6 | 2013 | 506 | 0.490 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2018 | 539 | 0.490 |
Why?
| | DNA, Intergenic | 4 | 2011 | 26 | 0.480 |
Why?
| | Plasmodium falciparum | 2 | 2015 | 30 | 0.470 |
Why?
| | Genes, Homeobox | 5 | 2013 | 51 | 0.470 |
Why?
| | Centromere | 1 | 2015 | 59 | 0.470 |
Why?
| | Neoplasms | 5 | 2019 | 2671 | 0.470 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 121 | 0.430 |
Why?
| | Nuclear Proteins | 3 | 2016 | 712 | 0.420 |
Why?
| | X Chromosome | 3 | 2024 | 53 | 0.420 |
Why?
| | Protein Binding | 12 | 2024 | 2224 | 0.410 |
Why?
| | Myoblasts | 3 | 2022 | 84 | 0.410 |
Why?
| | HeLa Cells | 8 | 2021 | 636 | 0.410 |
Why?
| | Systems Biology | 3 | 2011 | 67 | 0.410 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 150 | 0.400 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 139 | 0.400 |
Why?
| | Proteins | 7 | 2024 | 1009 | 0.400 |
Why?
| | RNA Interference | 7 | 2021 | 469 | 0.400 |
Why?
| | Adipogenesis | 1 | 2013 | 55 | 0.390 |
Why?
| | Retroelements | 1 | 2012 | 48 | 0.390 |
Why?
| | Brain | 2 | 2015 | 2668 | 0.390 |
Why?
| | HEK293 Cells | 7 | 2021 | 730 | 0.390 |
Why?
| | Homeostasis | 4 | 2021 | 621 | 0.380 |
Why?
| | Cells, Cultured | 16 | 2021 | 4193 | 0.380 |
Why?
| | Skin | 2 | 2008 | 752 | 0.380 |
Why?
| | Epidermis | 2 | 2012 | 157 | 0.360 |
Why?
| | RNA Stability | 5 | 2021 | 117 | 0.360 |
Why?
| | Human Embryonic Stem Cells | 2 | 2021 | 25 | 0.350 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2023 | 91 | 0.350 |
Why?
| | Conserved Sequence | 6 | 2020 | 239 | 0.340 |
Why?
| | Histones | 11 | 2021 | 636 | 0.330 |
Why?
| | Down-Regulation | 3 | 2016 | 657 | 0.330 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2020 | 30 | 0.320 |
Why?
| | Muscle Development | 3 | 2022 | 111 | 0.320 |
Why?
| | Chromosomes, Human, Pair 22 | 4 | 2004 | 45 | 0.320 |
Why?
| | Telomere | 2 | 2019 | 280 | 0.320 |
Why?
| | Gene Library | 4 | 2018 | 118 | 0.320 |
Why?
| | Single-Cell Analysis | 5 | 2020 | 313 | 0.310 |
Why?
| | Sex Characteristics | 2 | 2005 | 762 | 0.310 |
Why?
| | Gene Editing | 2 | 2021 | 80 | 0.310 |
Why?
| | CRISPR-Cas Systems | 3 | 2021 | 125 | 0.300 |
Why?
| | Mammals | 5 | 2021 | 283 | 0.300 |
Why?
| | MicroRNAs | 8 | 2021 | 692 | 0.300 |
Why?
| | Nucleotide Motifs | 3 | 2017 | 35 | 0.290 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2129 | 0.290 |
Why?
| | Immunity, Innate | 3 | 2019 | 828 | 0.280 |
Why?
| | Cell Lineage | 5 | 2021 | 350 | 0.280 |
Why?
| | Lymphopoiesis | 2 | 2021 | 26 | 0.280 |
Why?
| | Chromatin Assembly and Disassembly | 5 | 2017 | 104 | 0.270 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 32 | 0.270 |
Why?
| | Wnt Proteins | 1 | 2008 | 133 | 0.260 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 17 | 0.260 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 806 | 0.250 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3284 | 0.250 |
Why?
| | HCT116 Cells | 3 | 2021 | 80 | 0.240 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 320 | 0.240 |
Why?
| | Exons | 4 | 2016 | 355 | 0.230 |
Why?
| | Databases, Genetic | 4 | 2020 | 237 | 0.230 |
Why?
| | Genes, X-Linked | 1 | 2024 | 18 | 0.230 |
Why?
| | Myosin Heavy Chains | 2 | 2021 | 192 | 0.230 |
Why?
| | Male | 21 | 2024 | 67762 | 0.230 |
Why?
| | Genitalia | 1 | 2004 | 30 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 648 | 0.220 |
Why?
| | Motor Neurons | 3 | 2015 | 234 | 0.220 |
Why?
| | Signal Transduction | 11 | 2021 | 5079 | 0.220 |
Why?
| | Gene Knockdown Techniques | 4 | 2013 | 327 | 0.220 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2023 | 7 | 0.210 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 801 | 0.210 |
Why?
| | Alternative Splicing | 2 | 2018 | 229 | 0.200 |
Why?
| | Cluster Analysis | 5 | 2015 | 499 | 0.200 |
Why?
| | Databases, Nucleic Acid | 2 | 2021 | 34 | 0.200 |
Why?
| | Female | 23 | 2024 | 73304 | 0.200 |
Why?
| | Plasmids | 1 | 2023 | 363 | 0.200 |
Why?
| | Zebrafish | 4 | 2013 | 499 | 0.190 |
Why?
| | NF-kappa B | 4 | 2020 | 691 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 179 | 0.190 |
Why?
| | Mitosis | 2 | 2021 | 192 | 0.190 |
Why?
| | Ribonucleases | 2 | 2019 | 55 | 0.190 |
Why?
| | RNA Transport | 3 | 2016 | 23 | 0.190 |
Why?
| | Gene Targeting | 1 | 2021 | 81 | 0.180 |
Why?
| | Genetic Techniques | 2 | 2013 | 64 | 0.180 |
Why?
| | Mice, Inbred Strains | 2 | 2019 | 409 | 0.180 |
Why?
| | Cell Compartmentation | 1 | 2021 | 52 | 0.180 |
Why?
| | Ectoderm | 1 | 2021 | 53 | 0.180 |
Why?
| | Genetic Association Studies | 3 | 2014 | 377 | 0.180 |
Why?
| | Research Report | 1 | 2021 | 83 | 0.180 |
Why?
| | Cardiac Myosins | 1 | 2021 | 30 | 0.180 |
Why?
| | Stem Cells | 3 | 2022 | 594 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 976 | 0.180 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2022 | 218 | 0.170 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 24 | 0.170 |
Why?
| | Receptor, Insulin | 1 | 2021 | 105 | 0.170 |
Why?
| | Epigenomics | 2 | 2011 | 115 | 0.170 |
Why?
| | Spermatogenesis | 1 | 2020 | 67 | 0.170 |
Why?
| | Polycomb-Group Proteins | 3 | 2010 | 28 | 0.170 |
Why?
| | Lipopolysaccharides | 3 | 2019 | 886 | 0.170 |
Why?
| | Placenta | 3 | 2021 | 750 | 0.170 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 34 | 0.170 |
Why?
| | Eukaryotic Cells | 1 | 2020 | 40 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2021 | 233 | 0.160 |
Why?
| | Protein Domains | 2 | 2020 | 289 | 0.160 |
Why?
| | RNA Precursors | 1 | 2021 | 154 | 0.160 |
Why?
| | Species Specificity | 1 | 2021 | 585 | 0.160 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Dactinomycin | 1 | 2019 | 28 | 0.160 |
Why?
| | Immunoprecipitation | 2 | 2024 | 155 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 62 | 0.160 |
Why?
| | Embryo Implantation | 1 | 2019 | 30 | 0.160 |
Why?
| | Genome-Wide Association Study | 4 | 2020 | 1431 | 0.160 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2018 | 92 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2019 | 105 | 0.150 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 83 | 0.150 |
Why?
| | Organelles | 2 | 2017 | 58 | 0.150 |
Why?
| | Mice, Inbred C57BL | 10 | 2024 | 5757 | 0.150 |
Why?
| | Structure-Activity Relationship | 1 | 2020 | 570 | 0.150 |
Why?
| | RNA, Fungal | 2 | 2010 | 72 | 0.150 |
Why?
| | Apoptosis | 4 | 2018 | 2553 | 0.150 |
Why?
| | Pattern Recognition, Automated | 1 | 2019 | 73 | 0.150 |
Why?
| | Time Factors | 4 | 2024 | 6828 | 0.150 |
Why?
| | Protein Conformation | 2 | 2021 | 934 | 0.150 |
Why?
| | Transgenes | 3 | 2020 | 180 | 0.150 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2018 | 21 | 0.150 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2018 | 29 | 0.150 |
Why?
| | Binding, Competitive | 2 | 2020 | 202 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3412 | 0.150 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 55 | 0.150 |
Why?
| | Mutation | 6 | 2024 | 3958 | 0.150 |
Why?
| | HMGA2 Protein | 1 | 2018 | 9 | 0.150 |
Why?
| | Cell Proliferation | 7 | 2020 | 2475 | 0.150 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 283 | 0.140 |
Why?
| | Adipocytes | 1 | 2020 | 222 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2018 | 56 | 0.140 |
Why?
| | Cell Nucleolus | 1 | 2018 | 17 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2017 | 327 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2018 | 178 | 0.140 |
Why?
| | Macaca mulatta | 3 | 2023 | 166 | 0.140 |
Why?
| | Immunity | 1 | 2018 | 143 | 0.140 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2018 | 135 | 0.140 |
Why?
| | Translocation, Genetic | 1 | 2018 | 105 | 0.140 |
Why?
| | Consensus Sequence | 2 | 2016 | 73 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 257 | 0.140 |
Why?
| | Lymphocytes | 2 | 2017 | 397 | 0.140 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 31 | 0.140 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 77 | 0.140 |
Why?
| | Staining and Labeling | 1 | 2017 | 150 | 0.140 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 364 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2021 | 279 | 0.140 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 158 | 0.140 |
Why?
| | Splicing Factor U2AF | 1 | 2016 | 16 | 0.130 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2016 | 38 | 0.130 |
Why?
| | Histone Deacetylases | 1 | 2018 | 215 | 0.130 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.130 |
Why?
| | HLA-G Antigens | 1 | 2016 | 2 | 0.130 |
Why?
| | Genetic Testing | 1 | 2019 | 460 | 0.130 |
Why?
| | Genotype | 1 | 2021 | 1916 | 0.130 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 95 | 0.130 |
Why?
| | Kidney | 1 | 2004 | 1468 | 0.130 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2016 | 5 | 0.130 |
Why?
| | Support Vector Machine | 1 | 2016 | 38 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 752 | 0.130 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2015 | 12 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2016 | 124 | 0.120 |
Why?
| | Methylation | 5 | 2020 | 230 | 0.120 |
Why?
| | Myocardium | 1 | 2021 | 1002 | 0.120 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 19 | 0.120 |
Why?
| | Chondrocytes | 1 | 2018 | 212 | 0.120 |
Why?
| | PTEN Phosphohydrolase | 2 | 2016 | 167 | 0.120 |
Why?
| | Doxorubicin | 1 | 2017 | 362 | 0.120 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 268 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 22 | 0.120 |
Why?
| | Nervous System | 1 | 2015 | 67 | 0.120 |
Why?
| | Liver | 1 | 2004 | 1943 | 0.120 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 60 | 0.120 |
Why?
| | Pseudogenes | 2 | 2014 | 18 | 0.120 |
Why?
| | Genes | 1 | 2015 | 230 | 0.120 |
Why?
| | Gene Expression | 4 | 2015 | 1502 | 0.120 |
Why?
| | beta-Galactosidase | 1 | 2015 | 78 | 0.120 |
Why?
| | RNA, Protozoan | 1 | 2015 | 60 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2015 | 1738 | 0.120 |
Why?
| | Myeloid Cells | 1 | 2016 | 148 | 0.120 |
Why?
| | Erythrocytes | 1 | 2020 | 700 | 0.120 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 165 | 0.120 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 206 | 0.120 |
Why?
| | Gene Silencing | 2 | 2013 | 195 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 110 | 0.110 |
Why?
| | RNA, Catalytic | 1 | 2015 | 187 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 434 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 406 | 0.110 |
Why?
| | Lysine | 3 | 2020 | 294 | 0.110 |
Why?
| | Molecular Biology | 1 | 2015 | 59 | 0.110 |
Why?
| | Neocortex | 1 | 2014 | 38 | 0.110 |
Why?
| | Kinetics | 1 | 2018 | 1670 | 0.110 |
Why?
| | Pyramidal Cells | 1 | 2014 | 74 | 0.110 |
Why?
| | Protein Footprinting | 1 | 2014 | 11 | 0.110 |
Why?
| | Neurons | 2 | 2021 | 1590 | 0.110 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 81 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2018 | 630 | 0.110 |
Why?
| | Trophoblasts | 1 | 2016 | 199 | 0.110 |
Why?
| | Keratinocytes | 2 | 2012 | 249 | 0.110 |
Why?
| | Pregnancy | 4 | 2023 | 6763 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 37 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1091 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2011 | 155 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 558 | 0.100 |
Why?
| | Information Theory | 1 | 2013 | 5 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 596 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2015 | 290 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 806 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 2015 | 266 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.100 |
Why?
| | Ubiquitination | 1 | 2013 | 102 | 0.100 |
Why?
| | Protein Array Analysis | 1 | 2012 | 57 | 0.100 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 7 | 0.100 |
Why?
| | Registries | 1 | 2020 | 2035 | 0.090 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2167 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2012 | 19 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1783 | 0.090 |
Why?
| | Genes, Overlapping | 1 | 2011 | 2 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 186 | 0.090 |
Why?
| | Genome, Protozoan | 1 | 2011 | 3 | 0.090 |
Why?
| | Genes, Protozoan | 1 | 2011 | 13 | 0.090 |
Why?
| | Biological Evolution | 1 | 2015 | 474 | 0.090 |
Why?
| | Models, Statistical | 2 | 2024 | 669 | 0.090 |
Why?
| | Disease | 1 | 2012 | 98 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 129 | 0.090 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.090 |
Why?
| | Mitochondria | 2 | 2020 | 948 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 343 | 0.090 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 258 | 0.080 |
Why?
| | Argonaute Proteins | 3 | 2016 | 27 | 0.080 |
Why?
| | Sexual Maturation | 1 | 2010 | 55 | 0.080 |
Why?
| | Octamer Transcription Factor-3 | 2 | 2021 | 18 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 2409 | 0.080 |
Why?
| | Body Size | 1 | 2010 | 108 | 0.080 |
Why?
| | Thymus Gland | 2 | 2008 | 312 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2016 | 940 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 2 | 2010 | 557 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 2004 | 523 | 0.070 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 1043 | 0.070 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 70 | 0.070 |
Why?
| | Zebrafish Proteins | 2 | 2010 | 288 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 233 | 0.070 |
Why?
| | Myosin Type V | 1 | 2008 | 9 | 0.070 |
Why?
| | Viruses | 1 | 2009 | 113 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 316 | 0.070 |
Why?
| | Wnt-5a Protein | 1 | 2008 | 23 | 0.070 |
Why?
| | Proteome | 1 | 2012 | 472 | 0.070 |
Why?
| | Chromosome Disorders | 1 | 2008 | 43 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2139 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 658 | 0.070 |
Why?
| | Keratins | 1 | 2008 | 173 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2020 | 269 | 0.070 |
Why?
| | Cell Survival | 3 | 2016 | 1120 | 0.070 |
Why?
| | Autoantigens | 2 | 2008 | 430 | 0.070 |
Why?
| | Zinc Fingers | 1 | 2007 | 50 | 0.070 |
Why?
| | Retinol-Binding Proteins | 1 | 2006 | 18 | 0.070 |
Why?
| | Epithelium | 1 | 2008 | 313 | 0.070 |
Why?
| | Peptides | 1 | 2012 | 985 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 171 | 0.060 |
Why?
| | Bacteria | 2 | 2013 | 858 | 0.060 |
Why?
| | Software | 1 | 2012 | 665 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2007 | 82 | 0.060 |
Why?
| | ras Proteins | 1 | 2007 | 153 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 331 | 0.060 |
Why?
| | Breast Neoplasms | 2 | 2016 | 2253 | 0.060 |
Why?
| | Eye Proteins | 1 | 2006 | 92 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1704 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2009 | 483 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 843 | 0.060 |
Why?
| | Monocytes | 2 | 2020 | 563 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 332 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 622 | 0.060 |
Why?
| | Quantitative Trait Loci | 2 | 2020 | 380 | 0.060 |
Why?
| | Neoplastic Stem Cells | 1 | 2009 | 399 | 0.060 |
Why?
| | Transcortin | 1 | 2004 | 16 | 0.060 |
Why?
| | RNA Polymerase II | 2 | 2023 | 324 | 0.060 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.060 |
Why?
| | Biophysical Phenomena | 1 | 2024 | 64 | 0.060 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 115 | 0.050 |
Why?
| | Serpins | 1 | 2004 | 31 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 405 | 0.050 |
Why?
| | Testis | 1 | 2004 | 151 | 0.050 |
Why?
| | Hypothalamus | 1 | 2004 | 153 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 145 | 0.050 |
Why?
| | Virus Internalization | 1 | 2023 | 49 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2016 | 138 | 0.050 |
Why?
| | Endoderm | 1 | 2023 | 19 | 0.050 |
Why?
| | SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Poly A | 1 | 2003 | 51 | 0.050 |
Why?
| | Selection, Genetic | 1 | 2005 | 273 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 460 | 0.050 |
Why?
| | Ovary | 1 | 2004 | 221 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2022 | 17 | 0.050 |
Why?
| | Cytoskeletal Proteins | 2 | 2012 | 158 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 510 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 385 | 0.050 |
Why?
| | Histone Demethylases | 2 | 2015 | 32 | 0.050 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 16 | 0.050 |
Why?
| | Macrophages | 2 | 2020 | 1547 | 0.050 |
Why?
| | Smad1 Protein | 1 | 2020 | 18 | 0.040 |
Why?
| | Primates | 1 | 2022 | 126 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2020 | 8 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 209 | 0.040 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4295 | 0.040 |
Why?
| | Oligonucleotide Probes | 2 | 2015 | 51 | 0.040 |
Why?
| | Cochlear Nucleus | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.040 |
Why?
| | Bystander Effect | 1 | 2020 | 16 | 0.040 |
Why?
| | DNA Replication Timing | 1 | 2020 | 1 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 191 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2020 | 33 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1040 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 2020 | 39 | 0.040 |
Why?
| | Transposases | 1 | 2020 | 19 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 152 | 0.040 |
Why?
| | CpG Islands | 2 | 2015 | 157 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 656 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2000 | 50 | 0.040 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2020 | 95 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 185 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 103 | 0.040 |
Why?
| | Static Electricity | 1 | 2020 | 118 | 0.040 |
Why?
| | Karyotype | 1 | 2019 | 18 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 991 | 0.040 |
Why?
| | Karyotyping | 1 | 2019 | 104 | 0.040 |
Why?
| | Potassium Channels | 1 | 2000 | 151 | 0.040 |
Why?
| | Blastocyst | 1 | 2019 | 48 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 213 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 202 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 367 | 0.040 |
Why?
| | Cell Movement | 2 | 2016 | 967 | 0.040 |
Why?
| | Interphase | 1 | 2018 | 32 | 0.040 |
Why?
| | HL-60 Cells | 1 | 2018 | 34 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1178 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 365 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2837 | 0.040 |
Why?
| | Regenerative Medicine | 1 | 2018 | 49 | 0.040 |
Why?
| | Genes, Switch | 1 | 2018 | 6 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 12 | 0.040 |
Why?
| | Internet | 1 | 2003 | 655 | 0.040 |
Why?
| | Cytarabine | 1 | 2018 | 61 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2018 | 18 | 0.040 |
Why?
| | Biotinylation | 1 | 2017 | 32 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2018 | 115 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2018 | 67 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 66 | 0.040 |
Why?
| | Inhibitor of Differentiation Protein 2 | 1 | 2017 | 5 | 0.040 |
Why?
| | Antigens, CD | 1 | 2020 | 521 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2018 | 70 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2017 | 57 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 87 | 0.030 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 2016 | 5 | 0.030 |
Why?
| | Macaca | 1 | 2016 | 56 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2018 | 180 | 0.030 |
Why?
| | Mice, Nude | 2 | 2010 | 698 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2016 | 44 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 526 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2016 | 124 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 514 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 518 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 64 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1759 | 0.030 |
Why?
| | Immunogenetic Phenomena | 1 | 2016 | 7 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2016 | 56 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1060 | 0.030 |
Why?
| | RNA Polymerase III | 1 | 2016 | 28 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2020 | 771 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1129 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 1272 | 0.030 |
Why?
| | Mice, Inbred NOD | 2 | 2008 | 601 | 0.030 |
Why?
| | Heterochromatin | 1 | 2015 | 53 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 127 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 672 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 231 | 0.030 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2014 | 7 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 378 | 0.030 |
Why?
| | Blood | 1 | 2015 | 107 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1570 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 2014 | 5 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 118 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 71 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 945 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 239 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 404 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 207 | 0.030 |
Why?
| | Precipitin Tests | 2 | 2004 | 100 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 449 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1111 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 908 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2020 | 922 | 0.030 |
Why?
| | RNA Editing | 1 | 2014 | 24 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 978 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2015 | 162 | 0.030 |
Why?
| | Nucleosomes | 1 | 2015 | 155 | 0.030 |
Why?
| | Eosinophils | 1 | 2016 | 332 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 374 | 0.030 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2017 | 289 | 0.030 |
Why?
| | RNA Isoforms | 1 | 2013 | 1 | 0.030 |
Why?
| | Virus Replication | 1 | 2016 | 483 | 0.030 |
Why?
| | HapMap Project | 1 | 2013 | 5 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1226 | 0.030 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 14 | 0.030 |
Why?
| | Ataxins | 1 | 2013 | 4 | 0.030 |
Why?
| | Ataxin-1 | 1 | 2013 | 4 | 0.030 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2013 | 4 | 0.030 |
Why?
| | ELAV Proteins | 1 | 2013 | 14 | 0.030 |
Why?
| | Flagellin | 1 | 2013 | 17 | 0.030 |
Why?
| | Neurogenesis | 1 | 2014 | 149 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 81 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2013 | 372 | 0.020 |
Why?
| | Lung | 2 | 2018 | 4060 | 0.020 |
Why?
| | Cell Cycle | 1 | 2016 | 601 | 0.020 |
Why?
| | Multigene Family | 1 | 2013 | 198 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 144 | 0.020 |
Why?
| | Codon | 1 | 2012 | 89 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2085 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 248 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 123 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 327 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 213 | 0.020 |
Why?
| | RNA Folding | 1 | 2012 | 38 | 0.020 |
Why?
| | Genetic Research | 1 | 2011 | 16 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 32 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2426 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 41 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 325 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2012 | 163 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2011 | 42 | 0.020 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 53 | 0.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2012 | 52 | 0.020 |
Why?
| | Data Mining | 1 | 2012 | 116 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 194 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 175 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 267 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 313 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 366 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 220 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 189 | 0.020 |
Why?
| | Skin Diseases | 1 | 2012 | 149 | 0.020 |
Why?
| | PPAR gamma | 1 | 2012 | 182 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1238 | 0.020 |
Why?
| | Gene Dosage | 1 | 2011 | 140 | 0.020 |
Why?
| | Zygote | 1 | 2010 | 13 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 480 | 0.020 |
Why?
| | Lipopeptides | 1 | 2009 | 13 | 0.020 |
Why?
| | Bias | 1 | 2011 | 218 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2010 | 257 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 219 | 0.020 |
Why?
| | Poly I-C | 1 | 2009 | 63 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2009 | 77 | 0.020 |
Why?
| | Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| | HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| | Mice, SCID | 1 | 2010 | 367 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4149 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 298 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2009 | 56 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 185 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 353 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 384 | 0.020 |
Why?
| | Lacrimal Apparatus | 1 | 2008 | 9 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2009 | 118 | 0.020 |
Why?
| | Salivary Glands | 1 | 2008 | 33 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 126 | 0.020 |
Why?
| | Polyribosomes | 1 | 2008 | 24 | 0.020 |
Why?
| | Secretory Vesicles | 1 | 2008 | 23 | 0.020 |
Why?
| | Vacuoles | 1 | 2008 | 40 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 311 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2008 | 229 | 0.020 |
Why?
| | Eye | 1 | 2008 | 108 | 0.020 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 62 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 167 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 168 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2009 | 215 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 515 | 0.020 |
Why?
| | Actins | 1 | 2008 | 416 | 0.010 |
Why?
| | Uveitis | 1 | 2006 | 136 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 1972 | 0.010 |
Why?
| | Glucose | 1 | 2010 | 1020 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2004 | 190 | 0.010 |
Why?
| | Colforsin | 1 | 2004 | 53 | 0.010 |
Why?
| | Transcription Factor RelA | 1 | 2003 | 87 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1178 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2757 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4030 | 0.010 |
Why?
| | Shal Potassium Channels | 1 | 2000 | 6 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2000 | 54 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1353 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2186 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 316 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1242 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 33479 | 0.000 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|